Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stine Johansen

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Hepatology|March 1, 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver diseaseKatrine Holtz Thorhauge, Georg Semmler, Stine Johansen, et al.
JHEP Reports : Innovation in Hepatology|March 15, 2024
Infections increase the risk of decompensation and death in patients with early alcohol-related liver diseaseStine Johansen, Simon Langkjær, Ditlev Nytoft Rasmussen, et al.
The Lancet. Gastroenterology & Hepatology|March 9, 2023
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trialMads Israelsen, Bjørn Stæhr Madsen, Nikolaj Torp, et al.
JHEP Reports : Innovation in Hepatology|December 19, 2024
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intakeEmil Deleuran Hansen, Nikolaj Torp, Stine Johansen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2025
Steatotic Liver Disease Classification is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific TreatmentsMads Israelsen, Katrine Holtz Thorhauge, Peter Andersen, et al.
Gut|June 21, 2023
Impact of acute alcohol consumption on circulating microbiome in asymptomatic alcohol-related liver diseaseMads Israelsen, Camila Alvarez-Silva, Bjørn Stæhr Madsen, et al.
The Lancet. Gastroenterology & Hepatology|September 13, 2025
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort studyNikolaj Torp, Katrine Tholstrup Bech, Helle Lindholm Schnefeld, et al.
The American Journal of Clinical Nutrition|January 29, 2026
Health-related quality of life, compliance and sustained adherence on a Low-Carbohydrate High-Fat diet compared with a High-Carbohydrate Low-Fat diet in people with type 2 diabetesEllen Elise Petersen, Johanne Kragh Hansen, Nikolaj Torp, et al.
Journal of Hepatology|April 23, 2023
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver diseaseMaria Kjaergaard, Katrine Prier Lindvig, Katrine Holtz Thorhauge, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2023
Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation-related markersEvelina Stankevic, Mads Israelsen, Helene Baek Juel, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|March 1, 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver diseaseKatrine Holtz Thorhauge, Georg Semmler, Stine Johansen, et al.
JHEP Reports : Innovation in Hepatology|March 15, 2024
Infections increase the risk of decompensation and death in patients with early alcohol-related liver diseaseStine Johansen, Simon Langkjær, Ditlev Nytoft Rasmussen, et al.
The Lancet. Gastroenterology & Hepatology|March 9, 2023
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trialMads Israelsen, Bjørn Stæhr Madsen, Nikolaj Torp, et al.
JHEP Reports : Innovation in Hepatology|December 19, 2024
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intakeEmil Deleuran Hansen, Nikolaj Torp, Stine Johansen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2025
Steatotic Liver Disease Classification is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific TreatmentsMads Israelsen, Katrine Holtz Thorhauge, Peter Andersen, et al.
Gut|June 21, 2023
Impact of acute alcohol consumption on circulating microbiome in asymptomatic alcohol-related liver diseaseMads Israelsen, Camila Alvarez-Silva, Bjørn Stæhr Madsen, et al.
The Lancet. Gastroenterology & Hepatology|September 13, 2025
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort studyNikolaj Torp, Katrine Tholstrup Bech, Helle Lindholm Schnefeld, et al.
The American Journal of Clinical Nutrition|January 29, 2026
Health-related quality of life, compliance and sustained adherence on a Low-Carbohydrate High-Fat diet compared with a High-Carbohydrate Low-Fat diet in people with type 2 diabetesEllen Elise Petersen, Johanne Kragh Hansen, Nikolaj Torp, et al.
Journal of Hepatology|April 23, 2023
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver diseaseMaria Kjaergaard, Katrine Prier Lindvig, Katrine Holtz Thorhauge, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2023
Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation-related markersEvelina Stankevic, Mads Israelsen, Helene Baek Juel, et al.
Pageof 4